Event
AI driven drug discovery
📅 Date: November 18-20, 2025
📍 Location: Boston, MA, USA
Sarah Bernard,
BD Senior Director – North America
AI-Driven Drug Discovery conference
The AI-Driven Drug Discovery Conference is one of the key global events showcasing how artificial intelligence and machine learning are transforming early-stage drug research.
Bringing together experts from biopharma, biotech, and technology, the event highlights emerging tools, predictive models, and real-world case studies accelerating therapeutic innovation.
Axxam at the conference
Axxam will attend the conference to engage with scientific and industry leaders on the future of AI-powered hit identification and lead optimization—and how these innovations can integrate with trusted, high-quality experimental data.
Our Senior Director Sarah Bernard will be present throughout the event and available for 1:1 partnering meetings.
How we accelerate drug discovery through AI
We connect powerful AI tools with strong experimental validation. As a result, research starts with the right target and moves faster toward hit discovery.
Smarter Target Selection
We use biomedical analytics to identify targets and pathways linked to disease. This ensures early confidence in biological relevance.Direct Transfer to Wet-Lab Proof
CRISPR edits, expression profiling and functional assays convert digital predictions into measurable outcomes.Reliable Hit and Mechanism Validation
Our platforms evaluate compound activity, selectivity and mechanism. High-content imaging and electrophysiology reveal how molecules act inside cells.
With this approach, we reduce risk and speed up the transition from concept to lead.
Meet us in Boston
Whether you’re advancing a complex target, adopting new screening strategies, or looking to integrate AI into your discovery pipeline — let’s talk.
📩 Book a meeting with us:
CONTACT US or write us to request@axxam.com